Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116640097B reveals a metal-free sulfur-promoted route for high-purity triazoles. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110590771B details an efficient 5-step synthesis of [1,5-a]-pyridoimidazole-1-carbonitrile from 2-fluoropyridine, offering cost reduction in API manufacturing and scalable production capabilities.
Novel heating-promoted synthesis eliminates metal catalysts for 2-trifluoromethyl quinoline. Offers green chemistry benefits and scalable manufacturing for pharmaceutical intermediates.
Patent CN115093413B details a mild hypervalent iodine-mediated synthesis of spiroindole alkaloids, offering cost-effective routes for pharmaceutical intermediate manufacturing.
Patent CN111423381A reveals a mild palladium-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply chains.
Patent CN109384794A reveals protic acid catalyzed route. High yield, green chemistry. Reliable supplier for scale-up.
Novel microwave-assisted method for fluoro-3,4-dihydroisocoumarin derivatives. High yield, mild conditions, cost-effective supply chain solutions for pharma intermediates.
Patent CN107266414A reveals copper-catalyzed C-H amination for aminomethyl thiophenes. This method offers significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Novel Rh-catalyzed aminocarbonylation using dimethyl carbonate offers a green, high-yield route for acetamide production, ensuring cost-effective supply chain solutions.
Patent CN116640146A details a Pd-catalyzed one-pot synthesis. Offers high purity, scalable production, and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN114539198B details a novel Pd-catalyzed route for chroman amides. Offers cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel iodine-promoted synthesis of trifluoromethyl-triazoles via patent CN113105402B. A cost-effective, scalable route for high-purity pharmaceutical intermediates without heavy metals.
Patent CN114195711B details a novel Pd-catalyzed carbonylation route. Offers safer processing and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN117736120A reveals a metal-free synthesis route for β-fluoroalkyl-β-aminovinyl ketones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN119320392A details a green catalytic route for Rucaparib. This report analyzes cost reduction in API manufacturing and supply chain reliability for procurement teams.
Patent CN113896648B reveals nickel-catalyzed synthesis avoiding toxic CO gas. Delivers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115215814A details a novel Rh-catalyzed C-H activation route to isoxazolidines, offering mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Novel isoindolinone-derived unsaturated imine synthesis via binaphthyl phosphoric acid. Delivers high yield, scalable production, and cost advantages for pharmaceutical supply chains.